PO-164 Identification of the heterogeneous nuclear ribonucleoprotein K/J (hnRNP K/J) as a repressor of the inhibitor kappa B alpha (IκBα) gene in aggressive breast cancer cells

IntroductionAdvanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression and drug resistance. The transcription factor NF-κB is often activated constitutively in aggressive breast cancer cells and plays a...

Full description

Saved in:
Bibliographic Details
Published inESMO open Vol. 3; no. Suppl 2; p. A291
Main Authors Drouot, G, Besancenot, V, Taverniers, A, Grandemange, S, Becuwe, P, Touche, N
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.07.2018
Online AccessGet full text

Cover

Loading…
Abstract IntroductionAdvanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression and drug resistance. The transcription factor NF-κB is often activated constitutively in aggressive breast cancer cells and plays a significant role by inducing many target genes involved in tumour progression and drug resistance. Mechanisms controlling constitutive NF-kB activation are not all clearly understood. Among them, repression of the gene encoding the NF-κB inhibitor, IκBα is not well known. This protein controls NF-κB activation by sequestering it in the cytoplasmic compartment. The present study reports the identification of the hnRNP K/J protein, which is initially known for its role in mRNA splicing and translation, as a repressor of the IκBα gene expression.Material and methodsIdentification of hnRNP K/J protein on the IκBα promoter was carried out by DNA pull-down coupled with a mass spectrometry analysis, and chromatin immunoprecipitation (ChIP) using a specific polyclonal antibodies. The hnRNP K/J protein was overexpressed in breast cancer cell lines by transient transfection, and consequence on the IκBα expression and the proximal IκBα promoter activity was evaluated by RT-qPCR and gene reporter assay, respectively. The hnRNP K/J protein localization was visualised in cells by Western blotting using nuclear and cytoplasmic extracts.Results and discussionsThe IκBα gene is expressed higher in nonaggressive compared to aggressive breast cancer cells. We used previous data showing the importance of the proximal promoter at position −495 from the transcription site for DNA pull-down with nuclear protein extract from MCF-7 cells. Mass spectrometry analysis led to identify hnRNP K/J protein, whose the binding to this region of the proximal IκBα promoter was confirmed by ChIP. The IκBα expression at mRNA level and proximal IκBα promoter activity was strongly decreased in hnRNP K/J-overexpressing breast cancer cells, in contrast to the respective parental cells, suggesting the role of hnRNP K/J protein as a gene repressor.ConclusionThe identification of hnRNP K/J as a repressor of IκBα gene expression depicts a new molecular mechanism, which may contribute to the high constitutive NF-kB activation in aggressive breast cancer cells and suggests to take it into account in the development of new therapies targeting NF-kB pathway in advanced breast cancers.
AbstractList Advanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression and drug resistance. The transcription factor NF-κB is often activated constitutively in aggressive breast cancer cells and plays a significant role by inducing many target genes involved in tumour progression and drug resistance. Mechanisms controlling constitutive NF-kB activation are not all clearly understood. Among them, repression of the gene encoding the NF-κB inhibitor, IκBα is not well known. This protein controls NF-κB activation by sequestering it in the cytoplasmic compartment. The present study reports the identification of the hnRNP K/J protein, which is initially known for its role in mRNA splicing and translation, as a repressor of the IκBα gene expression. Identification of hnRNP K/J protein on the IκBα promoter was carried out by DNA pull-down coupled with a mass spectrometry analysis, and chromatin immunoprecipitation (ChIP) using a specific polyclonal antibodies. The hnRNP K/J protein was overexpressed in breast cancer cell lines by transient transfection, and consequence on the IκBα expression and the proximal IκBα promoter activity was evaluated by RT-qPCR and gene reporter assay, respectively. The hnRNP K/J protein localization was visualised in cells by Western blotting using nuclear and cytoplasmic extracts. The IκBα gene is expressed higher in nonaggressive compared to aggressive breast cancer cells. We used previous data showing the importance of the proximal promoter at position −495 from the transcription site for DNA pull-down with nuclear protein extract from MCF-7 cells. Mass spectrometry analysis led to identify hnRNP K/J protein, whose the binding to this region of the proximal IκBα promoter was confirmed by ChIP. The IκBα expression at mRNA level and proximal IκBα promoter activity was strongly decreased in hnRNP K/J-overexpressing breast cancer cells, in contrast to the respective parental cells, suggesting the role of hnRNP K/J protein as a gene repressor. The identification of hnRNP K/J as a repressor of IκBα gene expression depicts a new molecular mechanism, which may contribute to the high constitutive NF-kB activation in aggressive breast cancer cells and suggests to take it into account in the development of new therapies targeting NF-kB pathway in advanced breast cancers.
IntroductionAdvanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression and drug resistance. The transcription factor NF-κB is often activated constitutively in aggressive breast cancer cells and plays a significant role by inducing many target genes involved in tumour progression and drug resistance. Mechanisms controlling constitutive NF-kB activation are not all clearly understood. Among them, repression of the gene encoding the NF-κB inhibitor, IκBα is not well known. This protein controls NF-κB activation by sequestering it in the cytoplasmic compartment. The present study reports the identification of the hnRNP K/J protein, which is initially known for its role in mRNA splicing and translation, as a repressor of the IκBα gene expression.Material and methodsIdentification of hnRNP K/J protein on the IκBα promoter was carried out by DNA pull-down coupled with a mass spectrometry analysis, and chromatin immunoprecipitation (ChIP) using a specific polyclonal antibodies. The hnRNP K/J protein was overexpressed in breast cancer cell lines by transient transfection, and consequence on the IκBα expression and the proximal IκBα promoter activity was evaluated by RT-qPCR and gene reporter assay, respectively. The hnRNP K/J protein localization was visualised in cells by Western blotting using nuclear and cytoplasmic extracts.Results and discussionsThe IκBα gene is expressed higher in nonaggressive compared to aggressive breast cancer cells. We used previous data showing the importance of the proximal promoter at position −495 from the transcription site for DNA pull-down with nuclear protein extract from MCF-7 cells. Mass spectrometry analysis led to identify hnRNP K/J protein, whose the binding to this region of the proximal IκBα promoter was confirmed by ChIP. The IκBα expression at mRNA level and proximal IκBα promoter activity was strongly decreased in hnRNP K/J-overexpressing breast cancer cells, in contrast to the respective parental cells, suggesting the role of hnRNP K/J protein as a gene repressor.ConclusionThe identification of hnRNP K/J as a repressor of IκBα gene expression depicts a new molecular mechanism, which may contribute to the high constitutive NF-kB activation in aggressive breast cancer cells and suggests to take it into account in the development of new therapies targeting NF-kB pathway in advanced breast cancers.
Author Besancenot, V
Touche, N
Grandemange, S
Drouot, G
Taverniers, A
Becuwe, P
Author_xml – sequence: 1
  givenname: G
  surname: Drouot
  fullname: Drouot, G
  organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France
– sequence: 2
  givenname: V
  surname: Besancenot
  fullname: Besancenot, V
  organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France
– sequence: 3
  givenname: A
  surname: Taverniers
  fullname: Taverniers, A
  organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France
– sequence: 4
  givenname: S
  surname: Grandemange
  fullname: Grandemange, S
  organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France
– sequence: 5
  givenname: P
  surname: Becuwe
  fullname: Becuwe, P
  organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France
– sequence: 6
  givenname: N
  surname: Touche
  fullname: Touche, N
  organization: UMR7039 CNRS-Université de Lorraine, Centre de Recherche en Automatique de Nancy, Vandoeuvre-lès-Nancy, France
BookMark eNqNkUFu2zAQRYkiAZo6ucMsnYVikpZoaRkbaeo0qI0gXRMUNbToyqRAKgayy6YHKtBVDpFD9CSV6gbIMqv5GPD_Gc77RI6cd0gIMHrB2FRMMO68b9ElnLI8ubpc3PHsQuTiAznhNCuSGeXF0Rv9kZzFuKWUslnaN8UJ-b1eJUykf55-Lit0nTVWq856B95AVyPU2GHwG3ToHyK4B92gChBs6f9p3wbfoXXwdXID49rdfVsP8hxUBAUB24Ax-vCaZl1tS9v1jR-qbRXMQTVtrWC8fHmev_w6h2FQ_wrUZjM47R6hDKhiB1o5jQE0Nk08JcdGNRHP_tcR-f756n7xJbldXS8Xl7dJySkXSVXxTOesKIwxeWp4ilSZDHU5o5qnWcWE1nlVINeYl5QKo_qrVAxTnitBCzMdkfyQq4OPMaCRbbA7FR4lo3IAIF8ByAGAPACQPYDeOj9Ysd9vbzHIqC32X6hsQN3Jytv3hEwPIeVu-_7RfwHgS6ne
ContentType Journal Article
Copyright 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
2018 © 2018 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology.
Copyright_xml – notice: 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: 2018 © 2018 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology.
DBID 9YT
ACMMV
6I.
AAFTH
AAYXX
CITATION
DOI 10.1136/esmoopen-2018-EACR25.686
DatabaseName BMJ Open Access Journals
BMJ Journals:Open Access
ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
DatabaseTitle CrossRef
DatabaseTitleList

Database_xml – sequence: 1
  dbid: ACMMV
  name: BMJ Journals:Open Access
  url: https://journals.bmj.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2059-7029
EndPage A291
ExternalDocumentID 10_1136_esmoopen_2018_EACR25_686
S2059702920317312
GroupedDBID .1-
.FO
0R~
0SF
53G
5VS
9YT
AAEDW
AALRI
AAXUO
ACGFS
ACMMV
ADBBV
ADRAZ
ADVLN
AFRHN
AITUG
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BCNDV
EBS
FDB
GROUPED_DOAJ
HYE
KQ8
M48
M~E
O9-
OK1
RHI
ROL
RPM
Z5R
6I.
AAFTH
AFCTW
AAYXX
AFJKZ
CITATION
ID FETCH-LOGICAL-b2026-dd25c8199fff84f24e0af5ecb70c245d16cc8d9e2ce8b006fa742d1e428a609f3
IEDL.DBID 9YT
ISSN 2059-7029
IngestDate Thu Sep 26 17:50:06 EDT 2024
Thu Jul 20 20:16:52 EDT 2023
Wed Aug 21 03:27:02 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Suppl 2
Language English
License This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0
This is an open access article under the CC BY-NC license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b2026-dd25c8199fff84f24e0af5ecb70c245d16cc8d9e2ce8b006fa742d1e428a609f3
OpenAccessLink http://dx.doi.org/10.1136/esmoopen-2018-EACR25.686
ParticipantIDs crossref_primary_10_1136_esmoopen_2018_EACR25_686
elsevier_sciencedirect_doi_10_1136_esmoopen_2018_EACR25_686
bmj_primary_10_1136_esmoopen_2018_EACR25_686
PublicationCentury 2000
PublicationDate 20180700
PublicationDateYYYYMMDD 2018-07-01
PublicationDate_xml – month: 07
  year: 2018
  text: 20180700
PublicationDecade 2010
PublicationTitle ESMO open
PublicationYear 2018
Publisher Elsevier Ltd
Publisher_xml – name: Elsevier Ltd
SSID ssj0001742056
Score 2.0834324
Snippet IntroductionAdvanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour...
Advanced breast cancers do not respond well to therapies and represent a relevant focus for studying molecular mechanisms involved in the tumour progression...
SourceID crossref
elsevier
bmj
SourceType Aggregation Database
Publisher
StartPage A291
SummonAdditionalLinks – databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dTxQxFG0QEuOLUdSIH-Q--ACJhZlupzsTYwgQCGJAQtyEt0m_LrsgM-vsmujPkkd-BL_J285M4gPR6NM0mWkn6bltz2lv72XsjZeOVqXCcK0VcplKw41RGcfEu2HunMMYu_PoWB2M5OFZdrbA-uuKXQfO7pR2IZ_UqPmy8f3rjy0a8O-7jCSbfnZVh3eEeJrzve3dU5FtqFzdY0tCkl4PDn0d6Y87L6QGk5jWlR4FHyai6F18_tAYrT3m6uLu1eu3FWn_EXvYUUnYbrF_zBZ8tczuH3WH5U_Y9cknTjIF2ru42G3OQY1ApA_GwQ-mJvPxpP2hCmGNdQPNxNSxXMcADpMKPm4ewtq4Oj0-CcV10DPQ0LT-s3XTtzapxhNDk0MDl3o61bAD8RIvrH24vdm5_bkO4Uf0FejzKPBpjgUT_OHnYIPdNRBOEGZP2Wh_7_PuAe9SNHAjSL1x50RmiVQUiJhLFNInGjNvzTCxQmYuVdbmrvDC-jwMcNTU-S71JHq0SgocPGOLVV355wyQeL7yKAqboEzQa114S2pODQYYVN0Ke0sAlNM2CEcZxctAlT1eZcCrbPEqCa8VlvZI_UOddz2kZUdAWmJRkrn9tfaL__jjS_Yg2ln0_33FFufNN_-aWM7crEaj_QXZDfvJ
  priority: 102
  providerName: Scholars Portal
Title PO-164 Identification of the heterogeneous nuclear ribonucleoprotein K/J (hnRNP K/J) as a repressor of the inhibitor kappa B alpha (IκBα) gene in aggressive breast cancer cells
URI http://dx.doi.org/10.1136/esmoopen-2018-EACR25.686
https://dx.doi.org/10.1136/esmoopen-2018-EACR25.686
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NbtQwELZKKyEuFb-iBVZz4NBKmObHcRNx2q5alaKUqmpROUX-m-6Cmqyyy50LD4TEiYfoQ_AkjJ1EcKhAvUQ-xE6Ub5z5Ps94zNhLJyx5pUJzpSRyEQvNtZYZx8jZ3dxai6F2Z3ksD8_F0UV2scKSmyP4cSp33OKq8SdJEZ5xzvfHk9Mkey1zeYet-dLlfjIWH8_-rKuQ1iOnPiTt_GMA8ib66tPN_ugvH3Nwn6335BDGHZoP2IqrH7K7ZR_-fsR-nLznJDx-ff3W7a_FfsENGgQicjD1uS0NmYQjPQ-1L1WsWmhnugntJhRlmNXwbucItqb16fGJb26DWoCCtsuJbdphtFk9nWma8C18VvO5gj0IG3Nh6-31z73r79vgH0R3gboMop3-m6B9jvsSjLelFnxUYPGYnR_sn00OeX_sAtcJKTJubZIZIgoFIuYCE-EihZkzejcyichsLI3JbeES43I_aVHRJ7exIyGjZFRg-oSt1k3tnjJA4u7SYVKYCEWETqnCGVJoMk3RK7UN9oogqOZdYY0qCJJUVgNilUes6hCrCLENFg9Y3aLPmwHUqicVHVmoyND-23vzdi_4jN0LRhbSeZ-z1WX7xb0g0rLUo2ClI7Y2npTlh1GQ_nQtRf4b9aDvUA
link.rule.ids 315,783,787,867,24330,27561,27562,27868,27936,27937
linkProvider BMJ Publishing Group Ltd
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PO-164+Identification+of+the+heterogeneous+nuclear+ribonucleoprotein+K%2FJ+%28hnRNP+K%2FJ%29+as+a+repressor+of+the+inhibitor+kappa+B+alpha+%28I%CE%BAB%CE%B1%29+gene+in+aggressive+breast+cancer+cells&rft.jtitle=ESMO+open&rft.au=Drouot%2C+G.&rft.au=Besancenot%2C+V.&rft.au=Taverniers%2C+A.&rft.au=Grandemange%2C+S.&rft.date=2018-07-01&rft.issn=2059-7029&rft.eissn=2059-7029&rft.volume=3&rft.spage=A291&rft_id=info:doi/10.1136%2Fesmoopen-2018-EACR25.686&rft.externalDBID=n%2Fa&rft.externalDocID=10_1136_esmoopen_2018_EACR25_686
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2059-7029&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2059-7029&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2059-7029&client=summon